Efficacy of platinum in advanced triple-negative breast cancer with germline BRCA mutation determined by next generation sequencing
Lists
Only you see this
Abstract
Platinum-based regimens are more effective in patients with deleterious <i>gBRCA</i> mutations, but no difference in patients without <i>BRCA</i> gene mutations, so non-platinum is an option in patients without <i>BRCA</i> gene mutations considering the toxicity and side effect. And we recommend that patients with advanced TNBC should have <i>BRCA</i> gene test.
BibTeX
@inproceedings{wang2020efficacy,
author = {Nan Wang and Kun Li and Wenfa Huang and Weiyao Kong and Xiaoran Liu and Weijie Shi and Feng Xie and Hanfang Jiang and Guohong Song and Lijun Di and Quanren Wang and Jianjun Yu and Huiping Li and Jiangsu Hengrui Medicine, Shanghai 200120, China},
title = {{Efficacy of platinum in advanced triple-negative breast cancer with germline BRCA mutation determined by next generation sequencing}},
booktitle = {Chinese},
year = {2020},
doi = {10.21147/j.issn.1000-9604.2020.02.03},
}Loading related content...